As of 2025-07-11, the Relative Valuation of Amphastar Pharmaceuticals Inc (AMPH) is 40.33 USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.21 USD, the upside of Amphastar Pharmaceuticals Inc based on Relative Valuation is 81.6%.
The range of the Relative Valuation is 25.60 - 58.04 USD.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 13.5x | 10.2x |
| Forward P/E multiples | 11.9x - 18.2x | 15.7x |
| Fair Price | 25.60 - 58.04 | 40.33 |
| Upside | 15.3% - 161.3% | 81.6% |
| Date | P/E |
| 2025-07-10 | 7.39 |
| 2025-07-09 | 7.47 |
| 2025-07-08 | 7.52 |
| 2025-07-07 | 7.61 |
| 2025-07-03 | 7.72 |
| 2025-07-02 | 7.85 |
| 2025-07-01 | 7.77 |
| 2025-06-30 | 7.64 |
| 2025-06-27 | 7.68 |
| 2025-06-26 | 7.72 |
| 2025-06-25 | 7.81 |
| 2025-06-24 | 8.18 |
| 2025-06-23 | 8.21 |
| 2025-06-20 | 8.17 |
| 2025-06-18 | 8.43 |
| 2025-06-17 | 8.52 |
| 2025-06-16 | 8.65 |
| 2025-06-13 | 8.59 |
| 2025-06-12 | 8.80 |
| 2025-06-11 | 8.67 |
| 2025-06-10 | 8.96 |
| 2025-06-09 | 8.86 |
| 2025-06-06 | 8.65 |
| 2025-06-05 | 8.49 |
| 2025-06-04 | 8.61 |
| 2025-06-03 | 8.66 |
| 2025-06-02 | 8.45 |
| 2025-05-30 | 8.56 |
| 2025-05-29 | 8.53 |
| 2025-05-28 | 8.41 |
| 2025-05-27 | 8.50 |
| 2025-05-23 | 8.14 |
| 2025-05-22 | 8.05 |
| 2025-05-21 | 8.04 |
| 2025-05-20 | 8.34 |
| 2025-05-19 | 8.25 |
| 2025-05-16 | 8.27 |
| 2025-05-15 | 8.09 |
| 2025-05-14 | 7.76 |
| 2025-05-13 | 7.95 |
| 2025-05-12 | 8.10 |
| 2025-05-09 | 8.02 |
| 2025-05-08 | 8.20 |
| 2025-05-07 | 8.13 |
| 2025-05-06 | 7.95 |
| 2025-05-05 | 8.36 |
| 2025-05-02 | 8.15 |
| 2025-05-01 | 7.95 |
| 2025-04-30 | 8.12 |
| 2025-04-29 | 8.15 |